NWWA
CTSO icon

New Wave Wealth Advisors’s Cytosorbents Corp CTSO Stock Holding History

New Wave Wealth Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,631
Closed -$1.48K – 251
2024
Q4 		$1.48K Buy
+1,631
New +$1.6K ﹤0.01% 588

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New Wave Wealth Advisors's CTSO Position: Q1 2025 in Review

New Wave Wealth Advisors sold out of Cytosorbents Corp (CTSO) in Q1 2025, closing a stake of 1,631 shares — an estimated $1.48K sold.

New Wave Wealth Advisors first reported a position in CTSO in Q4 2024 and held it in 1 quarter. The position peaked at $1.48K in Q4 2024. 49 funds tracked by Wall St. Rank hold CTSO as of Q1 2025.

  • New Wave Wealth Advisors reported no remaining Cytosorbents Corp position as of Q1 2025 after selling out during the quarter.
  • New Wave Wealth Advisors sold 1,631 Cytosorbents Corp shares in Q1 2025, an estimated $1.48K.
  • New Wave Wealth Advisors first reported a position in Cytosorbents Corp in Q4 2024 and held it in 1 quarter.
  • New Wave Wealth Advisors's Cytosorbents Corp position peaked at $1.48K in Q4 2024.
  • 49 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2025.

Based on New Wave Wealth Advisors's 13F filing for Q1 2025, filed 25 Apr 2025.